Hemophilia Treatment Drugs Market
07-Jan-2019 | Number of pages: 186 | Report Id: BMRC PH 133 | Report Format: | Status: Published

Hemophilia Treatment Drugs Market By Disease (Hemophilia A, Hemophilia B), By Product Type (Recombinant Coagulation Factor Concentrates, Plasma Derived Coagulation Factor Concentrates), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), Industry Analysis, Trends, and Forecast 2019 – 2025

 

 

Hemophilia Treatment Drugs Market is valued around USD 18091.26 Million in 2018 and expected to reach USD 25660.57 Million by 2025 with the CAGR of 5.3% over the forecast period. Increased prevalence of hemophilia and technological advancements are the key drivers for Global Hemophilia Treatment Drugs Market.

Hemophilia Treatment Drugs market report published by the Brandessence Market Research and Consulting Pvt. Ltd. provides the detail information about hemophilia treatment drugs market from various aspects. This report consists of drivers, restrains, Opportunities which help the market to grow over the analysis period and recent trends which support the growth of market. This report consists of regional segmentation with product type, disease type and distribution channel.

Hemophilia is a X chromosome linked genetic disorder which is also known as royal blood disease. In this condition, blood loses its ability to clot by itself due to the absence of clotting factor. Hemophilia is of various types which includes hemophilia A, hemophilia B, acquired and others. It can be easily diagnosed with the help of blood test and on the basis of severity required precautions can be taken. Its treatment includes introduction of clotting factors and in severe cases blood infusion is also required.

Hemophilia Treatment Drugs market Size

 

There are various factors driving the growth of the hemophilia treatment drugs market, one of the major factors driving the growth of this market is increased prevalence of hemophilia over the period of time. As per the Centers for Disease Control and Prevention 2016 report, Hemophilia A affects 1 in 5,000 male births. About 400 babies are born with hemophilia A each year. Moreover, increased awareness among people is also expected to support the growth of hemophilia treatment drugs market over the forecast period. Furthermore, there are various major players in the hemophilia treatment drugs market which are constantly working for the development of new drug for the better treatment of hemophilia. However, low rate of diagnosis are likely to hamper the growth of hemophilia treatment drugs market.

Hemophilia Treatment Drugs market Analysis

Hemophilia Treatment Drugs Market Revenue (USD Million) Analysis by Regional and Global, 2019-2025

Global Hemophilia Treatment Drugs market report covers prominent players like CSL Behring, Shire Plc., Pfizer Inc, BioMarin, Baxalta, Bayer Healthcare, Novo Nordisk, Biogen, F. Hoffmann-La Roche AG and others.

Hemophilia Treatment Drugs Market Segmentation –

By Disease Analysis:

  • Hemophilia A
  • Hemophilia B
  • Others

By Product Type Analysis

  • Recombinant Coagulation Factor Concentrates
  • Plasma Derived Coagulation Factor Concentrates
  • Desmopressin
  • Antifibrinolytic Agents

By Distribution Channel Analysis

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce

By Regional & Country Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Hemophilia Treatment Drugs Market Key Players

CSL Behring
Shire Plc.
Pfizer Inc
BioMarin
Bayer Healthcare
Novo Nordisk
Biogen
Hoffmann-La Roche AG

 

 

  1. Chapter – Report Methodology
    • Research Process
    • Primary Research
    • Secondary Research
    • Market Size Estimates
    • Data Triangulation
    • Forecast Model
    • USP’s of Report
    • Report Description
  2. Chapter – Global Hemophilia Treatment Drugs Market Overview: Qualitative Analysis
    • Market Introduction
    • Executive Summary
    • Global Hemophilia Treatment Drugs Market Classification
    • Market Drivers
    • Market Restraints
    • Market Opportunity
    • Hemophilia Treatment Drugs Market: Trends
    • Porter’s Five Forces Analysis
      • Bargaining Power of Suppliers
      • Bargaining Power of Consumers
      • Threat of New Entrants
      • Threat of Substitute Product and Services
      • Competitive Rivalry within the Industry
    • Market Attractiveness Analysis
      • Market Attractiveness Analysis by Segmentation
      • Market Attractiveness Analysis by Region
  1. Chapter – Global Hemophilia Treatment Drugs Market Overview: Quantitative Analysis
    • Global Hemophilia Treatment Drugs Market Consumption, Market Share ( %) and Growth Rate, 2015-2025
    • Global Hemophilia Treatment Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2015-2025
  2. Chapter – Global Hemophilia Treatment Drugs Market Analysis: by Disease
  3. Chapter-Global Hemophilia Treatment Drugs Market Analysis: by Product Type
  4. Chapter-Global Hemophilia Treatment Drugs Market Analysis: by Distribution Channel
  5. Chapter – Global Hemophilia Treatment Drugs Market Analysis: by Manufacturer
    • Global Hemophilia Treatment Drugs Market Revenue (USD Million), by Manufacturer, 2015 – 2018
    • Global Hemophilia Treatment Drugs Market Consumption, Manufacturer, 2015 – 2018
    • Global Hemophilia Treatment Drugs Market Share (%), by Manufacturer, 2018
    • Global Hemophilia Treatment Drugs Market Price (USD/Unit), by Manufacturer, 2015 – 2018
    • Global Hemophilia Treatment Drugs Market Revenue Growth Rate (%), by Manufacturer, 2015 – 2018
    • Merger & Acquisition
    • Collaborations and Partnership
    • New Product Launch
  6. Chapter – Hemophilia Treatment Drugs Market: Regional Analysis
    • North America
      • North America Hemophilia Treatment Drugs Market Revenue (USD Million) and Growth Rate (%), 2015 – 2025.
      • North America Hemophilia Treatment Drugs Market Revenue (USD Million) By Country, 2015 – 2025.
      • North America Hemophilia Treatment Drugs Revenue Market Share (%) By Country, 2015 – 2025.
      • North America Hemophilia Treatment Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015 – 2025.
      • North America Hemophilia Treatment Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015 – 2025.
      • North America Hemophilia Treatment Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015 – 2025.
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  7. Chapter – Company Profiles
    • CSL Behring
      • Overview
      • Financials
      • Product portfolio
      • Hemophilia Treatment Drugs Market Revenue (USD Million), Consumption  and Market Share (%), 2015 – 2018
      • Hemophilia Treatment Drugs Sales Market Share (%), 2015 – 2018
      • Business strategy
      • Recent developments
    • Shire Plc.
    • Pfizer Inc
    • BioMarin
    • Bayer Healthcare
    • Novo Nordisk
    • Biogen
    • Hoffmann-La Roche AG
    • Others
  8. Chapter – Market Research and Findings

 

CSL Behring
Shire Plc.
Pfizer Inc
BioMarin
Bayer Healthcare
Novo Nordisk
Biogen
Hoffmann-La Roche AG